{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-022771","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2021-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.729721+00:00","generated_at":"2026-06-29T01:00:22.006615+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genprex appoints Dr. Berger as CMO and Dr. Kumar as CMTO, effective Sept 27, 2021","bullets":["Mark S. Berger, M.D. named Chief Medical Officer; annual base salary $450,000 plus up to 40% bonus and 550k stock option at $2.85/sh.","Hemant Kumar, Ph.D. named Chief Manufacturing and Technology Officer; base salary $325,000 plus up to 40% bonus and 400k stock option at $2.85/sh.","Both roles are newly created; Berger and Kumar report to CEO Rodney Varner.","Berger previously CMO at Actinium Pharmaceuticals; Kumar most recently VP at Arcturus Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-022771","json":"https://secwatch.observer/filing/0001437749-21-022771.json","markdown":"https://secwatch.observer/filing/0001437749-21-022771.md","text":"https://secwatch.observer/filing/0001437749-21-022771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774921022771/0001437749-21-022771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774921022771/gnpx20210928_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:00:22.006615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d65a83bace","claim":"Mark S. Berger, M.D. was appointed as Chief Medical Officer at Genprex, Inc..","evidence_excerpt":"Effective as of September 27, 2021, the Board of Directors (the \"Board\") of Genprex, Inc. (\"Genprex\") appointed Mark S. Berger, M.D. as Chief Medical Officer of Genprex.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774921022771/0001437749-21-022771-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}